Veterinary Histopathology Market Report 2026

The veterinary histopathology market size has grown strongly in recent years. It will grow from $0.98 billion in 2025 to $1.07 billion in 2026 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to increasing prevalence of animal infectious diseases and cancers, growing demand for accurate tissue-based diagnosis in veterinary care, expansion of veterinary laboratory infrastructure in urban regions,manual microscopic examination as primary diagnostic method in veterinary pathology, limited adoption of digital pathology tools in veterinary diagnostics.

The veterinary histopathology market size is expected to see strong growth in the next few years. It will grow to $1.51 billion by 2030 at a compound annual growth rate (CAGR) of 9%. The growth in the forecast period can be attributed to integration of AI-powered diagnostic pathology systems in veterinary labs, rising adoption of digital histopathology and remote consultation services, increasing demand for precision medicine in animal healthcare, expansion of automated tissue processing and imaging systems, growing investment in advanced veterinary diagnostic infrastructure. Major trends in the forecast period include AI-assisted digital histopathology image analysis for early disease detection in animals, cloud-based veterinary pathology data sharing platforms for collaborative diagnosis, automated tissue slide scanning and digital microscopy workflows in veterinary labs, advanced biomarker-based staining techniques for improved cancer and infection detection, integrated lab automation systems for high-throughput veterinary tissue processing.

The rising prevalence of animal diseases is expected to propel the growth of the veterinary histopathology market going forward. Animal diseases refer to disorders or infections that affect the health of domestic and wild animals, impacting their wellbeing, productivity, and sometimes posing risks to humans. The rising prevalence of animal diseases is driven by intensified livestock farming, as higher animal density increases the risk of infections and facilitates faster disease spread. Veterinary histopathology helps detect, diagnose, and monitor animal diseases by examining tissue samples at the cellular level, enabling accurate identification of infections, cancers, and other pathological conditions. For example, in March 2026, according to the Swine Health Org, a US-based health information center, IAV positivity reached 42.2% in wean-to-market pigs and 27.4% in adult/sow farms, while PEDV positivity rose to 12.6%, hitting 14% in adult/sow farms and 17.5% in wean-to-market pigs. Therefore, the rising prevalence of animal diseases is driving the growth of the veterinary histopathology market.

Leading companies operating in the veterinary histopathology market are focusing on the development of advanced solutions, such as rapid nucleosome-based cancer screening, to improve diagnostic accuracy, enable early detection of diseases, and enhance treatment planning. Rapid nucleosome-based cancer screening refers to a technological capability in veterinary histopathology that quantifies nucleosomes to screen and monitor canine cancer, assisting veterinarians in prioritizing cases that require immediate attention. For example, in November 2023, Antech, a UK-based veterinary diagnostics company and part of Mars Petcare’s science and diagnostics division, launched its comprehensive UK laboratory in Warwick. Designed to support veterinary care teams with full-service diagnostics, the laboratory provides Key Screen for DNA-based GI parasite screening, AIS RapidRead for imaging diagnostics in under 10 minutes, and the upcoming NuQ platform for nucleosome measurement, integrating advanced laboratory, imaging, and software solutions to enhance pet health outcomes.

In March 2025, Aiforia, a Finland-based provider of artificial intelligence (AI) solutions for veterinary histopathology and pathology, partnered with PathPresenter. Through this collaboration, Aiforia and PathPresenter aim to speed up the adoption of digital pathology and AI in veterinary histopathology by facilitating faster, more precise, and remote evaluation of animal tissue samples. PathPresenter is a US-based digital pathology image management and workflow platform.

Major companies operating in the veterinary histopathology market are Iowa State VDL, IDEXX Laboratories Inc., Eurofins Scientific SE, Antech Diagnostics Inc., Wisconsin Veterinary Diagnostic Laboratory, Cornell Animal Health Diagnostic Center, Prairie Diagnostic Services Inc., Veterinary Diagnostic Services Inc., VetLesions (Veterinary Lesions LLC), StageBio Inc., Mississippi Veterinary Research & Diagnostic Laboratory, Pennsylvania Animal Diagnostic Laboratory System, Veterinary Pathology Group Inc., Anivive Lifesciences Inc., VDx Veterinary Diagnostics LLC, Texas A&M Veterinary Medical Diagnostic Laboratory, Kansas State Veterinary Diagnostic Laboratory, Oregon Veterinary Diagnostic Laboratory, Cytopath Veterinary Pathology LLC, Veterinary Healthcare Company Limited.

North America was the dominating region in the veterinary histopathology market in 2025. Asia Pacific is expected to be the rapidly expanding region during the forecast period. The regions covered in the veterinary histopathology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the veterinary histopathology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The veterinary histopathology market consists of revenues earned by entities by providing services such as routine histopathological examination, biopsy evaluation, necropsy (post-mortem) tissue analysis, and oncology pathology services. The market value includes the value of related goods sold by the service provider or included within the service offering. The veterinary histopathology market also includes sales of paraffin wax, microtome blades, special stain kits, and microscope glass slides. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.